XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.1

STOCKHOLDERS' EQUITY | 9 Months Ended
--- | ---
Mar. 31, 2022
Equity [Abstract] |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Changes in the components of Stockholders’ equity were as follows for the periods indicated:
| Three Months Ended March 31
(Dollars in millions except per share data; shares in thousands) | Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Net (Loss) Income |  | Non-controlling interests |  | Total Stockholders’ Equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of December 31, 2020 | $ | 131 |  |  | 130,741 |  |  | $ | 1,176 |  |  | $ | 1,302 |  |  | $ | (850) |  |  | (5,017) |  |  | $ | (575) |  |  | $ | 196 |  |  | $ | 1,380 |
Net earnings (losses) | — |  |  | — |  |  | — |  |  | (61) |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | (59) |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 22 |  |  | — |  |  | 22 |
Dividends to Clorox stockholders ($1.11 per share declared) | — |  |  | — |  |  | — |  |  | (139) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (139) |
Dividends to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |
Stock-based compensation | — |  |  | — |  |  | 17 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 17 |
Other employee stock plan activities | — |  |  | — |  |  | (3) |  |  | (16) |  |  | 44 |  |  | 283 |  |  | — |  |  | — |  |  | 25 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (305) |  |  | (1,648) |  |  | — |  |  | — |  |  | (305) |
Balance as of March 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,190 |  |  | $ | 1,086 |  |  | $ | (1,111) |  |  | (6,382) |  |  | $ | (553) |  |  | $ | 195 |  |  | $ | 938 |
Balance as of December 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,180 |  |  | $ | 949 |  |  | $ | (1,373) |  |  | (7,777) |  |  | $ | (574) |  |  | $ | 178 |  |  | $ | 491 |
Net earnings | — |  |  | — |  |  | — |  |  | 150 |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 152 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 55 |  |  | — |  |  | 55 |
Dividends to Clorox stockholders ($1.16 per share declared) | — |  |  | — |  |  | — |  |  | (143) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (143) |
Dividends to non-controlling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Stock-based compensation | — |  |  | — |  |  | 19 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 19 |
Other employee stock plan activities | — |  |  | — |  |  | (4) |  |  | (5) |  |  | 15 |  |  | 107 |  |  | — |  |  | — |  |  | 6 |
Balance as of March 31, 2022 | $ | 131 |  |  | 130,741 |  |  | $ | 1,195 |  |  | $ | 951 |  |  | $ | (1,358) |  |  | (7,670) |  |  | $ | (519) |  |  | $ | 176 |  |  | $ | 576 |
| Nine Months Ended March 31
(Dollars in millions except per share data; shares in thousands) | Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Net (Loss) Income |  | Non-controlling interests |  | Total Stockholders’ Equity
Amount |  | Shares |  |  |  | Amount |  | Shares |  |  |
Balance as of June 30, 2020 | $ | 159 |  |  | 158,741 |  |  | $ | 1,137 |  |  | $ | 3,567 |  |  | $ | (3,315) |  |  | (32,543) |  |  | $ | (640) |  |  | $ | — |  |  | $ | 908 |
Net earnings | — |  |  | — |  |  | — |  |  | 613 |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 619 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 87 |  |  | — |  |  | 87 |
Dividends to Clorox stockholders ($3.33 per share declared) | — |  |  | — |  |  | — |  |  | (421) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (421) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (9) |  |  | (9) |
Business combinations including purchase accounting adjustments | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 198 |  |  | 198 |
Stock-based compensation | — |  |  | — |  |  | 52 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 52 |
Other employee stock plan activities | — |  |  | — |  |  | 1 |  |  | (33) |  |  | 141 |  |  | 1,233 |  |  | — |  |  | — |  |  | 109 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (605) |  |  | (3,072) |  |  | — |  |  | — |  |  | (605) |
Treasury stock retirement (1) | (28) |  |  | (28,000) |  |  | — |  |  | (2,640) |  |  | 2,668 |  |  | 28,000 |  | $ | — |  |  | — |  |  | — |
Balance as of March 31, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,190 |  |  | $ | 1,086 |  |  | $ | (1,111) |  |  | (6,382) |  |  | $ | (553) |  |  | $ | 195 |  |  | $ | 938 |
Balance as of June 30, 2021 | $ | 131 |  |  | 130,741 |  |  | $ | 1,186 |  |  | $ | 1,036 |  |  | $ | (1,396) |  |  | (7,961) |  |  | $ | (546) |  |  | $ | 181 |  |  | $ | 592 |
Net earnings | — |  |  | — |  |  | — |  |  | 361 |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | 367 |
Other comprehensive (loss) income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 27 |  |  | — |  |  | 27 |
Dividends to Clorox stockholders ($3.48 per share declared) | — |  |  | — |  |  | — |  |  | (430) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (430) |
Dividends to noncontrolling interests | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11) |  |  | (11) |
Stock-based compensation | — |  |  | — |  |  | 44 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 44 |
Other employee stock plan activities | — |  |  | — |  |  | (35) |  |  | (16) |  |  | 63 |  |  | 443 |  |  | — |  |  | — |  |  | 12 |
Treasury stock purchased | — |  |  | — |  |  | — |  |  | — |  |  | (25) |  |  | (152) |  |  | — |  |  | — |  |  | (25) |
Balance as of March 31, 2022 | $ | 131 |  |  | 130,741 |  |  | $ | 1,195 |  |  | $ | 951 |  |  | $ | (1,358) |  |  | (7,670) |  |  | $ | (519) |  |  | $ | 176 |  |  | $ | 576 |
(1) On November 18, 2020 the Company retired 28 million shares of its treasury stock. These shares are now authorized but unissued. There was no effect on the Company’s overall equity position as a result of the retirement. Changes in Accumulated other comprehensive net (loss) income attributable to Clorox by component were as follows for the periods indicated:
| Three Months Ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of December 31, 2020 | $ | (403) |  |  | $ | (3) |  |  | $ | (169) |  |  | $ | (575) |
Other comprehensive (loss) income before reclassifications | (6) |  |  | 33 |  |  | — |  |  | 27 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | 2 |  |  | 3 |  |  | 5 |
Income tax benefit (expense) | (1) |  |  | (8) |  |  | (1) |  |  | (10) |
Net current period other comprehensive (loss) income | (7) |  |  | 27 |  |  | 2 |  |  | 22 |
Balance as of March 31, 2021 | $ | (410) |  |  | $ | 24 |  |  | $ | (167) |  |  | $ | (553) |
Balance as of December 31, 2021 | $ | (431) |  |  | $ | 18 |  |  | $ | (161) |  |  | $ | (574) |
Other comprehensive (loss) income before reclassifications | 19 |  |  | 48 |  |  | — |  |  | 67 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (3) |  |  | 2 |  |  | (1) |
Income tax benefit (expense), and other | — |  |  | (11) |  |  | — |  |  | (11) |
Net current period other comprehensive (loss) income | 19 |  |  | 34 |  |  | 2 |  |  | 55 |
Balance as of March 31, 2022 | $ | (412) |  |  | $ | 52 |  |  | $ | (159) |  |  | $ | (519) |
| Nine Months Ended March 31
| Foreign currency translation adjustments |  | Net unrealized gains (losses) on derivatives |  | Pension and postretirement benefit adjustments |  | Accumulated other comprehensive net (loss) income
Balance as of June 30, 2020 | $ | (450) |  |  | $ | (18) |  |  | $ | (172) |  |  | $ | (640) |
Other comprehensive (loss) income before reclassifications | 38 |  |  | 47 |  |  | — |  |  | 85 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | 7 |  |  | 7 |  |  | 14 |
Income tax benefit (expense) | 2 |  |  | (12) |  |  | (2) |  |  | (12) |
Net current period other comprehensive (loss) income | 40 |  |  | 42 |  |  | 5 |  |  | 87 |
Balance as of March 31, 2021 | $ | (410) |  |  | $ | 24 |  |  | $ | (167) |  |  | $ | (553) |
Balance as of June 30, 2021 | $ | (403) |  |  | $ | 21 |  |  | $ | (164) |  |  | $ | (546) |
Other comprehensive (loss) income before reclassifications | (9) |  |  | 51 |  |  | — |  |  | 42 |
Amounts reclassified from Accumulated other comprehensive net (loss) income | — |  |  | (10) |  |  | 6 |  |  | (4) |
Income tax benefit (expense), and other | — |  |  | (10) |  |  | (1) |  |  | (11) |
Net current period other comprehensive (loss) income | (9) |  |  | 31 |  |  | 5 |  |  | 27 |
Balance as of March 31, 2022 | $ | (412) |  |  | $ | 52 |  |  | $ | (159) |  |  | $ | (519) |
Included in foreign currency translation adjustments are remeasurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future. There were no amounts associated with these loans reclassified from Accumulated other comprehensive net (loss) income for the periods presented.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration